Dear Foregen Supporters,
Welcome back to our most recent newsletter! We have some important updates for you, and an overview of the best parts of March.
What’s Happened Since Last Time?
- A quick PSA for everyone: we will be switching to a once a month newsletter to provide more substantive updates and better meet supporters’ expectations
- This past week Foregen met with representatives of Flanders Investment & Trade in Brussels, Belgium. Discussions were primarily focused on facilities options for human clinical trials and funding to carry out said trials. This development is a potential option that we are exploring for the future phases of Foregen’s research.
- We’ve been invited by Flanders Investment & Trade to attend an event in Ghent, Belgium called Knowledge for Growth on May 9th, where we will seek networking and connections to help carry out our plans for research and human clinical trials.
- We are happy to announce our tissue supplier has found the necessary foreskins for our research and will be sourcing, collecting and sending them to us in the next few months.
- We have our summary posted here about the interactions and connections we made at SXSW, so give it a read!
- We have changed the date for the HuFo exhibit that we previously announced, which will now start on June 4th at Open Space Studio in Philadelphia. Foregen supporters and anyone interested in talking with our founder and seeing the exhibit is invited - it’s open to the public and entry is free.
- For the month of March we reached a total of $9,150 in donations, which helps us move forward with the next parts of our mission! Be sure to inform other activists, friends and family about Foregen and the science we’re pursuing to one day help provide genital integrity to men around the world. Our overall total to date is $441,872 - Let’s keep it up.
Tell Me Something Interesting
- A recent article in Nature describes a fascinating development with HIV treatment, where ‘a person with HIV seems to be free of the virus after receiving a stem-cell transplant that replaced their white blood cells with HIV-resistant versions. The patient is only the second person ever reported to have been cleared of the virus using this method. But researchers warn that it is too early to say that they have been cured. The patient — whose identity hasn’t been disclosed — was able to stop taking antiretroviral drugs, with no sign of the virus returning 18 months later. The stem-cell technique was first used a decade ago for Timothy Ray Brown, known as the ‘Berlin patient’, who is still free of the virus.’
Volunteer for Foregen - We Want Your Help
Thanks for reading, and stay tuned for our next newsletter. If you’d like more frequent updates, please head over to our blog, or visit one of our social media accounts – the links are at the bottom of this newsletter.
The Foregen Team